Haematologica (Jul 2007)

Chronic myelomonocytic leukemia in the light of the WHO proposals

  • Ulrich Germing,
  • Corinna Strupp,
  • Sabine Knipp,
  • Andrea Kuendgen,
  • Aristoteles Giagounidis,
  • Barbara Hildebrandt,
  • Carlo Aul,
  • Rainer Haas,
  • Norbert Gattermann,
  • John M. Bennett

DOI
https://doi.org/10.3324/haematol.11051
Journal volume & issue
Vol. 92, no. 7

Abstract

Read online

The WHO classification moved CMML to myeloproliferative/myelodysplastic disorders, and defined CMML I and CMML II according to medullary and peripheral blast count. To confirm these proposals, we analyzed 266 patients with CMML I and 73 patients with CMML II. Median survival time was 20 months for CMML I, and 15 months for CMML II (p